Amgen launches an AbbVie Humira biosimilar in the U.S.
- ByInvesting.com-
By Sam Boughedda After a dip earlier in the session, AbbVie (NYSE:ABBV) shares are now slightly up on the day, holding steady, despite Amgen (NASDAQ:AMGN) announcing AMJEVITA, a...